Research Topics
Species | Bonnie I GlanzSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Cognitive deterioration in patients with early multiple sclerosis: a 5-year studyBonnie I Glanz
Department of Neurology, Brigham and Women s Hospital, Boston, Massachusetts, USA
J Neurol Neurosurg Psychiatry 83:38-43. 2012..Methodological issues associated with longitudinal cognitive research such as practice effects and drop-outs were also examined...- Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosisB I Glanz
Department of Neurology, Brigam and Women s Hospital, Harvard Medical School, Boston, MA, USA
Mult Scler 13:1004-10. 2007..These findings suggest that cognitive impairment may predate the appearance of gross structural abnormalities on MRI and serve as an early marker of disease activity in MS... - The association between cognitive impairment and quality of life in patients with early multiple sclerosisBonnie I Glanz
Department of Neurology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
J Neurol Sci 290:75-9. 2010..Our results suggest that cognitive remediation programs aimed at improving cognitive skills may also improve quality of life for patients with early MS... - Patient reported outcomes in benign multiple sclerosisLine E Hviid
Partners Multiple Sclerosis Center, Brigham and Women s Hospital Harvard Medical Institute, Brookline, MA 02445, USA
Mult Scler 17:876-84. 2011..Benign MS patients have a mild course of disease and show no or minimal accumulation of disability over time. Little is known about the patient reported outcomes (PROs) in benign MS... - Rate of brain atrophy in benign vs early multiple sclerosisSusan A Gauthier
Department of Neurology, Partners Multiple Sclerosis Center, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Arch Neurol 66:234-7. 2009..Benign multiple sclerosis (MS) is defined by minimal or no disability after many years of observation, therefore a less degenerative disease process is suspected to be present in this subset of patients... - Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosisJames M Stankiewicz
Department of Neurology, Brigham and Women s Hospital, Partners MS Center, Harvard Medical School, Brookline, Massachusetts 02445, USA
J Neuroimaging 21:e50-6. 2011..To assess correlation between brain lesions and clinical status with 1.5T and 3T magnetic resonance imaging (MRI)... - Smoking and disease progression in multiple sclerosisBrian C Healy
Department of Neurology, Partners MS Center, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Arch Neurol 66:858-64. 2009..Although cigarette smokers are at increased risk of developing multiple sclerosis (MS), the effect of smoking on the progression of MS remains uncertain... - Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal studyJennifer Moodie
Department of Neurology, University of Massachusetts, Boston, MA, USA
J Neurol Sci 315:49-54. 2012..We previously described a composite MRI scale combining T1-lesions, T2-lesions and whole brain atrophy in multiple sclerosis (MS): the magnetic resonance disease severity scale (MRDSS)... - A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosisZongqi Xia
Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women s Hospital, Boston, Massachusetts, United States of America
PLoS ONE 5:e14169. 2010..We used a candidate gene approach to address whether genetic variants implicated in susceptibility to late onset Alzheimer's Disease (AD) influence brain volume and cognition in MS patients... - Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosisMohit Neema
Department of Neurology, Brigham and Women s Hospital, Partners MS Center, Harvard Medical School, Boston, Massachusetts 02115, USA
J Neuroimaging 19:3-8. 2009..Conventional brain MRI lesion measures have unreliable associations with clinical progression in multiple sclerosis (MS). Gray matter imaging may improve clinical-MRI correlations... - A method for evaluating treatment switching criteria in multiple sclerosisBrian C Healy
Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women s Hospital, Boston, MA, USA
Mult Scler 16:1483-9. 2010..We investigated a method to evaluate a treatment switching approach, namely treatment change after one multiple sclerosis (MS) relapse... - A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB studySusan A Gauthier
Partners Multiple Sclerosis Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Autoimmun Rev 5:532-6. 2006..Advances in our ability to clinically measure and monitor the disease through MRI imaging technology, immunology, and genetic analysis provide the opportunity to address these critical questions... - Predicting short-term disability in multiple sclerosisS A Gauthier
Partners Multiple Sclerosis Center, Brigham and Women s Hospital, Brookline, MA 02445, USA
Neurology 68:2059-65. 2007..To develop covariate specific short-term disability curves to demonstrate the probability of progressing by Expanded Disability Status Scale (EDSS) at semiannual visits... - Lateralized cognitive dysfunction in patients with systemic lupus erythematosusB I Glanz
Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Lupus 14:896-902. 2005..The observed deficits were not clearly attributable to vascular lesions and suggest immune-mediated effects on specific brain regions in a subgroup of patients with SLE...